All Episodes

May 24, 2025 4 mins
# Wegovy's Changing Landscape: FDA Bans, Price Drops, and Healthcare Evolution

Explore the latest developments in the Wegovy (semaglutide) story as host Alexandra Reeves breaks down the FDA's recent crackdown on unauthorized compounded versions of this popular weight loss medication. Learn how Novo Nordisk is responding with new pricing initiatives, including limited-time offers of $199 for first-time users and ongoing $499 monthly options—a significant reduction from previous costs. This episode examines how telehealth companies are revolutionizing access to Wegovy while also investigating the safety concerns that prompted regulatory action. Discover the medication's proven benefits beyond weight loss, including significant cardiovascular improvements revealed in the SELECT trial, alongside important safety considerations. From Hollywood influence to global supply challenges, this comprehensive analysis covers how Wegovy continues to transform both individual lives and the healthcare industry at large. #Wegovy #WeightLossMedication #ObesityTreatment #Semaglutide #HealthcareInnovation #FDA #Telehealth
Mark as Played

Advertise With Us

Popular Podcasts

Stuff You Should Know
The Joe Rogan Experience

The Joe Rogan Experience

The official podcast of comedian Joe Rogan.

Dateline NBC

Dateline NBC

Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Special Summer Offer: Exclusively on Apple Podcasts, try our Dateline Premium subscription completely free for one month! With Dateline Premium, you get every episode ad-free plus exclusive bonus content.

Music, radio and podcasts, all free. Listen online or download the iHeart App.

Connect

© 2025 iHeartMedia, Inc.